Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new version (2022-10-17) updates the study's recruitment status to terminated due to enrollment difficulties and consideration of clinical guidelines. The record history lists the version and its changes.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedSummary: The page now displays a status/operational notice and a version upgrade to v3.2.0, replacing the prior v3.1.0. Key impact is to inform users about current operating status and where to check details.SummaryDifference13%

- Check46 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new version. The 'Back to Top' link was removed as a minor UI change.SummaryDifference0.8%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%

- Check75 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related details have been removed.SummaryDifference6%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.